DOJ
All Coverage
Feds probe drug maker for prices of generic dermatology meds
Consumer safety agency says Indian company sold improperly packaged drugs
Two former device maker execs go on trial for unauthorized marketing
Novartis and the feds squabble over 80,000 ‘sham’ speaking events
